Cogent Biosciences Inc (NASDAQ: COGT) on Tuesday, soared 6.63% from the previous trading day, before settling in for the closing price of $4.98. Within the past 52 weeks, COGT’s price has moved between $3.72 and $12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -33.00% over the past five years. The company achieved an average annual earnings per share of 7.46%. With a float of $94.03 million, this company’s outstanding shares have now reached $113.86 million.
Let’s look at the performance matrix of the company that is accounted for 205 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cogent Biosciences Inc is 17.41%, while institutional ownership is 100.05%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 7.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.63% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Cogent Biosciences Inc (COGT) is currently performing well based on its current performance indicators. A quick ratio of 5.13 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.38, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -1.91 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Cogent Biosciences Inc (NASDAQ: COGT) saw its 5-day average volume 0.71 million, a negative change from its year-to-date volume of 1.36 million. As of the previous 9 days, the stock’s Stochastic %D was 60.41%. Additionally, its Average True Range was 0.42.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 24.73%, which indicates a significant decrease from 56.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.95% in the past 14 days, which was higher than the 78.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.51, while its 200-day Moving Average is $8.47. Nevertheless, the first resistance level for the watch stands at $5.47 in the near term. At $5.63, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.92. If the price goes on to break the first support level at $5.02, it is likely to go to the next support level at $4.73. Assuming the price breaks the second support level, the third support level stands at $4.57.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
Market capitalization of the company is 604.58 million based on 113,856K outstanding shares. Right now, sales total 0 K and income totals -255,860 K. The company made 0 K in profit during its latest quarter, and -71,990 K in sales during its previous quarter.
